Bystander activation of cytotoxic T cells: Studies on the mechanism and evaluation of in vivo significance in a transgenic mouse model

被引:152
作者
Ehl, S
Hombach, J
Aichele, P
Hengartner, H
Zinkernagel, RM
机构
[1] Institute of Experimental Immunology, Department of Pathology, University of Zürich
[2] Institute of Experimental Immunology, Department of Pathology, University of Zürich, CH-8091 Zürich
关键词
LYMPHOCYTIC CHORIOMENINGITIS VIRUS; RECEPTOR-ALPHA CHAINS; CLASS-I; MICE; INDUCTION; EXPRESSION; INFECTION; ANTIGEN; MOLECULES; TOLERANCE;
D O I
10.1084/jem.185.7.1241
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Bystander activation, i.e., activation of T cells specific for an antigen X during an immune response against antigen Y may occur during viral infections. However, the low frequency of bystander-activated T cells has rendered it difficult to define the mechanisms and possible in vivo relevance of this nonspecific activation. This study uses transgenic mice expressing a major histocompatibility complex class I-restricted TCR specific for glycoprotein peptide 33-41 of lymphocytic choriomeningitis virus (LCMV) to overcome this Limitation. CD8(+) T cells from specific pathogen-free maintained, unimmunized ''naive'' TCR transgenic mice can differentiate into LCMV-specific cytolytic effector CTL during infections with vaccinia virus or Listeria monocytogenes in vivo or mixed lymphocyte culture in vitro. We show that in these model situations (a) nonspecifically activated CTL are able to confer antiviral protection in vivo, (b) bystander activation is largely independent of the expression of a second T cell receptor of different specificity, (c) bystander activation is not mediated by a broadly cross-reactive TCR, but rather by cytokines, (d) bystander activation can be mediated by cytokines such as IL-2, but not alpha/beta-IFN in vitro; (e) bystander activation is, overall, a rare event, occuring in vivo in roughly 1 in 200 of the LCMV-specific CTL during infection of TCR transgenic mice with vaccinia virus; (f) bystander activation does not have a significant functional impact on nontransgenic CTL memory under the conditions tested; and (g) even in the TCR transgenic situation, where unphysiologically high numbers of T cells of a single specificity are present, bystander activation is not sufficient to cause clinically manifest autoimmune disease in a transgenic mouse model of diabetes. We conclude that although bystander activation via cytokines may generate cytolytically active CTL from naive precursors, quantitative considerations suggest that this is usually not of major biological consequence.
引用
收藏
页码:1241 / 1251
页数:11
相关论文
共 34 条
[1]   Immunopathology or organ-specific autoimmunity as a consequence of virus infection [J].
Aichele, P ;
Bachmann, MF ;
Hengartner, H ;
Zinkernagel, RM .
IMMUNOLOGICAL REVIEWS, 1996, 152 :21-45
[2]   THE SYNERGY BETWEEN NAIVE AND MEMORY T-CELLS DURING ACTIVATION [J].
AKBAR, AN ;
SALMON, M ;
JANOSSY, G .
IMMUNOLOGY TODAY, 1991, 12 (06) :184-188
[3]   QUANTIFICATION OF LYMPHOCYTIC CHORIOMENINGITIS VIRUS WITH AN IMMUNOLOGICAL FOCUS ASSAY IN 24-WELL OR 96-WELL PLATES [J].
BATTEGAY, M ;
COOPER, S ;
ALTHAGE, A ;
BANZIGER, J ;
HENGARTNER, H ;
ZINKERNAGEL, RM .
JOURNAL OF VIROLOGICAL METHODS, 1991, 33 (1-2) :191-198
[4]   IS T-CELL MEMORY MAINTAINED BY CROSS-REACTIVE STIMULATION [J].
BEVERLEY, PCL .
IMMUNOLOGY TODAY, 1990, 11 (06) :203-205
[5]   EXCLUSION AND INCLUSION OF ALPHA-T-CELL AND BETA-T-CELL RECEPTOR ALLELES [J].
BORGULYA, P ;
KISHI, H ;
UEMATSU, Y ;
VONBOEHMER, H .
CELL, 1992, 69 (03) :529-537
[6]   T-CELL RECEPTOR GENES IN A SERIES OF CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX-RESTRICTED CYTOTOXIC LYMPHOCYTE-T CLONES SPECIFIC FOR A PLASMODIUM-BERGHEI NONAPEPTIDE - IMPLICATIONS FOR T-CELL ALLELIC EXCLUSION AND ANTIGEN-SPECIFIC REPERTOIRE [J].
CASANOVA, JL ;
ROMERO, P ;
WIDMANN, C ;
KOURILSKY, P ;
MARYANSKI, JL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (06) :1371-1383
[7]   CROSS-REACTIVITY OF SELF-HLA-RESTRICTED EPSTEIN-BARR VIRUS-SPECIFIC CYTO-TOXIC LYMPHOCYTES-T FOR ALLO-HLA DETERMINANTS [J].
GASTON, JSH ;
RICKINSON, AB ;
EPSTEIN, MA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 158 (06) :1804-1821
[8]   MINIMUM STRUCTURAL REQUIREMENTS FOR PEPTIDE PRESENTATION BY MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II MOLECULES - IMPLICATIONS IN INDUCTION OF AUTOIMMUNITY [J].
GAUTAM, AM ;
LOCK, CB ;
SMILEK, DE ;
PEARSON, CI ;
STEINMAN, L ;
MCDEVITT, HO .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (02) :767-771
[9]   EXPRESSION OF 2 T-CELL RECEPTOR-ALPHA CHAINS ON THE SURFACE OF NORMAL MURINE T-CELLS [J].
HEATH, WR ;
CARBONE, FR ;
BERTOLINO, P ;
KELLY, J ;
COSE, S ;
MILLER, JFAP .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (06) :1617-1623
[10]   EXPRESSION OF 2 ALPHA-CHAINS ON THE SURFACE OF T-CELLS IN T-CELL RECEPTOR TRANSGENIC MICE [J].
HEATH, WR ;
MILLER, JFAP .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (05) :1807-1811